Kb Financial Partners, LLC Organon & Co. Transaction History

Kb Financial Partners, LLC

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$16.59 - $23.77 $0 - $0	0 New	0 $0
Q1 2023 May 16, 2023	SELL	$21.42 - $32.08 $21 - $32	-1 Reduced 3.85%	25 $1,000
Q4 2022 Feb 17, 2023	SELL	$23.31 - $28.61 $769 - $944	-33 Reduced 55.93%	26 $1,000
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $277,246 - $340,647	-8,757 Reduced 99.33%	59 $2,000
Q1 2022 May 17, 2022	BUY	$30.45 - $39.36 $20,614 - $26,646	677 Added 8.32%	8,816 $308,000
Q4 2021 Feb 18, 2022	BUY	$28.67 - $37.13 $233,345 - $302,201	8,139 New	8,139 $248,000
Q3 2021 Nov 16, 2021	SELL	$28.63 - $35.64 $944 - $1,176	-33 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$28.45 - $38.0 $938 - $1,254	33 New	33 $1,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kb Financial Partners, LLC with notifications on news.